ArticleBMC pulmonary medicine2026
Construction and validation of a prognostic nomogram for predicting short-term mortality in acute respiratory failure patients: a retrospective cohort study based on the MIMIC-IV database.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveThis study aimed to identify short-term mortality risk factors for patients with acute respiratory failure (ARF) the MIMIC-IV database, construct a prognostic nomogram and evaluate its predictive performance compared to conventional scoring systems.
methodsClinical data from patients diagnosed with ARF were retrospectively collected from the MIMIC-IV database and randomly divided into training and validation groups. The variables were selected via the Lasson regression, and a nomogram was constructed. The nomogram was compared with acute physiology score III (APSIII), simplified acute physiology scores II (SAPS II) and oxford acute severity of illness score (OASIS) model via the C-index, area under the receiver operating characteristic curve (ROC), net reclassification index (NRI), integrated discrimination improvement index (IDI), decision curve analysis (DCA).
resultsA total of 559 patients were included. The study identified nine independent risk factors: age (HR: 1.022, 95% CI: 1.008-1.036, P = 0.002), WBC (HR: 1.060, 95% CI:1.033-1.086, P < 0.001), glucose levels (HR:1.002, 95% CI: 1.001-1.004, P = 0.003), temperature (HR: 0.544, 95% CI: 0.430-0.689, P < 0.001), metastatic solid tumor (HR: 2.138, 95% CI: 1.045-4.372, P = 0.037), malignant cancer (HR: 2.455, 95% CI: 1.456-4.138, P < 0.001), diabetes without chronic complications (HR: 0.288, 95% CI: 0.157-0.807, P < 0.001), cerebrovascular disease (HR: 2.156, 95% CI: 1.180-3.940, P = 0.012), dementia (HR: 2.23, 95% CI: 1.132-4.392, P = 0.020). The nomogram demonstrated strong discriminative performance with C-indices of 0.782 and 0.749 in the training and validation sets, respectively. The AUC for the Training and Validation cohorts were 0.811 (APS III: 0.652; SAPS II: 0.672; OASIS: 0.624) and 0.790 (APS III: 0.634; SAPS II: 0.652; OASIS: 0.609), respectively. The nomogram also significantly outperformed traditional scoring systems, as evidenced by positive NRI and IDI values.
conclusionThe newly developed nomogram exhibits superior predictive capability to traditional scoring systems (APS III, SAPS II and OASIS scores), offering clinicians a practical and reliable tool for accurately assessing short-term mortality risks in ICU patients with ARF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.